| Joseph A. Ziegler |
Joseph A. Ziegler currently works at Jz Advisory Group, as Chief Executive Officer, Progressive Care, Inc., as Independent Director from 2021, and TherapeuticsMD, Inc., as Chief Financial & Accounting Officer from 2023. Mr. Ziegler also formerly worked at Jarden Corp., as Principal, Miami Subs Corp., as Principal, Value Rent-A-Car, Inc., as Principal, Global Tower LLC, as Principal, Proven Pharmaceuticals LLC, as Chief Financial Officer from 2009 to 2012, Encompass Onsite LLC, as Chief Financial Officer, and DAS Health Ventures LLC, as Chief Financial Officer in 2021. Mr. Ziegler received his undergraduate degree and Masters Business Admin degree from Florida Atlantic University. |
| Marlan D. Walker |
Marlan D. Walker is currently the Chief Executive Officer at TherapeuticsMD, Inc. He previously worked as the Intellectual Property Counsel at Medicis Pharmaceutical Corp. from 2011 to 2012. Mr. Walker has an undergraduate degree and a graduate degree from Brigham Young University. He also holds a graduate degree from George Washington University Law School, which he obtained in 2005. Additionally, he has a graduate degree from Sandra Day O'Connor College of Law, which he received in 2004. |
| Bharat Warrier |
Bharat Warrier is currently the Chief Manufacturing Officer at TherapeuticsMD, Inc. He has a graduate degree from the University of Missouri-Kansas City and an undergraduate degree from Sri Ramachandra Institute of Higher Education & Research. |
| Tommy George Thompson |
Tommy George Thompson is currently the Chairman of EdLogics LLC, the Executive Chairman of TherapeuticsMD, Inc., the Chairman of HealthcarePays Network LLC, and the Independent Director of United Therapeutics Corp. He also holds positions as a Director in various organizations including Accordia Global Health Foundation, Medical Missions For Children, Inc., US Biologic, Inc., Scilex, Inc., Healthpeak Properties, Inc., American Gene Technologies International, Inc., The District of Columbia Bar, State Bar of Wisconsin, Havencrest Capital Management LLC, and 37celsius Capital Partners LLC. In his former roles, Dr. Thompson served as the Chairman & Chief Executive Officer of Thompson Holdings, Inc., Chairman of AGA Medical Holdings, Inc., CareView Communications, Inc., OptumServe Health Services, Inc., The Deloitte Center for Health Solutions, The Global Fund to Fight AIDS, Tuberculosis & Malaria, National Governors Association, Education Commission of the States, Midwestern Governors Conference, Vital Decisions LLC, Physicians Realty Trust, C. R. Bard, Inc., SpectraScience, Inc., PURE Bioscience, Inc., Centene Corp., Medco Health Solutions, Inc., Voyager Pharmaceutical Corp., ProCure Treatment Centers, Inc., MYnd Analytics, Inc., Harmony Information Systems, Inc., X-Shares Advisors LLC, Tenex Health, Inc., Tyme Technologies, Inc., Well Nation Ltd., Picis Clinical Solutions, Inc., Cancer Genetics, Inc., VeriChip Corp., Plus Therapeutics, Inc., AGA Medical Corp., Tyme, Inc., Cytori Therapeutics, Inc., Vyant Bio, Inc., Scilex Holding Co., Healthpeak Properties, Inc. (Old), Physicians Realty LP, Akin, Gump, Strauss, Hauer & Feld LLP, and Burrill LLC. Dr. Thompson's education includes an undergraduate and graduate degree from the University of Wisconsin. |
| C. Christine Miller |
C. Christine Miller is currently the Chief Operating Officer at Sirion Holdings, Inc. and the Chief Regulatory & Quality Officer at TherapeuticsMD, Inc. Her former positions include being an Associate Director-Regulatory Affairs at Bayer Corp. from 1991 to 1994, Global Vice President-Drug Regulatory Affairs at Bausch & Lomb, Inc. from 1994 to 2001, an Associate at AMAG Pharma USA, Inc. in 1986 and 1987, Vice President-Regulatory & Quality Assurance at Santarus, Inc. from 2001 to 2006, Senior Vice President-Drug Development at Sirion Therapeutics, Inc. from 2006 to 2010, and Chief Operating Officer at Rx Development Resources LLC from 2006 to 2010. She also worked as an Associate at Mallinckrodt Medical, Inc. (US) from 1987 to 1991. Dr. Miller is the President of Pharmareg Solutions Ltd. She holds a doctorate degree from the University of Nebraska. |
| Cooper C. Collins |
Cooper C. Collins is currently the Chief Executive Officer at Dominion Aesthetic Technologies, Inc. and Fortis BioPharma. He is also an Independent Director at TherapeuticsMD, Inc. and a Managing Partner & CIO at Magnasci Ventures. Previously, he held positions such as President, Chief Executive Officer & Director at Golf Trust of America, Inc., President & Chief Executive Officer at Pernix Therapeutics LLC, and Chief Executive Officer at Pernix Therapeutics, Inc. He has also served as a Director at Oncternal Oncology, Inc. and Chief Strategy Officer at Pernix Therapeutics Holdings, Inc. Mr. Collins completed his undergraduate degree and MBA at Nicholls State University. |
| Gail K. Naughton |
Gail K. Naughton is the founder of Advanced Tissue Sciences, Inc. (1991), Histogen, Inc. (2007), and Histogen, Inc. (2005). She is currently the Chairman at La Jolla Institute For Immunology, Executive Chairman at BiOHIP, Inc., Director at CEL-SCI Corp., Independent Director at TherapeuticsMD, Inc., Director at Octet Medical, Inc., Head-Regenerative Therapeutics & Commercialization at HippoFi, Inc., and Professor at City University of New York. Her former positions include Independent Director at C. R. Bard, Inc. (New Jersey) (2004-2017), Director at Kratos Technology & Training Solutions, Inc., Director at Celera Corp. (2008-2011), Director at DermTech Operations, Inc., Independent Director at Plus Therapeutics, Inc. (2014-2018), Director at City of Hope National Cancer Institute, Director at Centre For Commercialization of Regenerative Medicine, and Advisor at Proteus RM LLC (Venture Capital). Dr. Naughton has an MBA from the University of California, Los Angeles, an undergraduate degree from St. Francis College, and graduate and doctorate degrees from New York University School of Medicine. |
| Jules A. Müsing |
Jules A. Müsing is a businessperson who has been at the helm of 5 different companies is on the board of Delphi Digital, Inc. and TherapeuticsMD, Inc. In his past career he occupied the position of Director at ZyVersa Therapeutics, Inc., President for Pitman-Moore, Inc., Vice President-Licensing & Acquisitions at Johnson & Johnson and Managing Director at Janssen Farmaceutica Portugal Lda. (a subsidiary of Johnson & Johnson), Managing Director at Biotech Ortho SAS and President of EMD Serono, Inc.
Mr. Müsing received an undergraduate degree from the University of Antwerp and a graduate degree from Vrije Universiteit Brussel. |
